Доступне лікування діабету: стратегії розробки економічно ефективних неінвазивних систем моніторингу рівня глюкози
The article examines the development of optical non-invasive methods for determining blood glucose levels in diabetic patients. The primary aim of the study is to explore various techniques for measuring glucose concentration, including traditional methods such as chemical blood analysis, obtained through finger pricks or venous sampling from the forearm, as well as alternative non-invasive approaches. The research focuses on identifying the advantages of non-invasive monitoring, which include avoiding pain and risks associated with sharp objects and enabling more frequent testing, thus ensuring tighter glucose control. The work also highlights the potential commercial benefits of non-invasive glucose monitoring devices. Research methods include optical technologies and a review of scientific literature. The results outline the feasibility of developing non-invasive optoelectronic devices and techniques to improve the accuracy of measuring blood components. The proposed technique and optical sensor are expected to significantly enhance the precision of non-invasive blood component measurements by considering the internal structure of capillaries and the condition of the skin. It is recommended to combine this method with other recognized non-invasive techniques for determining blood components in vivo, such as glucose, bilirubin, and oxygen, as this approach alone cannot fully address the challenges of non-invasive blood analysis in diabetic patients. The conclusions emphasize the significance of core optical technologies for non-invasive glucose monitoring and their cost-effectiveness compared to their advantages and limitations
Publication Details
- Journal
- The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
- Published
- 2024-12-26
- Primary Topic
- Spectroscopy Techniques in Biomedical and Chemical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00